O&G SAQs · Antenatal care — obstetric haemorrhage
Antepartum haemorrhage — structured SAQ (15 marks)
FRANZCOG-format structured SAQ on undifferentiated antepartum haemorrhage at 32 weeks: parallel resuscitation and fetal assessment, the discriminating differential, anti-D and Kleihauer with ANZ doses, and disposition by gestation and severity. Per-sub-part marking rubric included.
On this page
Study tools
Target exams
How this SAQ is marked
Twelve SAQs, 180 marks, two 2-hour papers — roughly 15 marks and 20 minutes each. Marks come from specifics: the named drug, the dose, the route, the threshold, the time window. Write labelled short points, answer the sub-part you were asked, and never spend a mark restating the stem. [1]
Reveal model answer and mark schemeShowHide
(a) Immediate assessment and resuscitation, first fifteen minutes (5 marks)
One mark per point, maximum five. A mark is available for stating that maternal resuscitation and fetal assessment happen in parallel. [1][2]
- Call for help and declare the emergency — obstetric consultant, anaesthetist, midwifery coordinator, blood bank; escalate to the massive obstetric haemorrhage protocol if loss exceeds 1000 mL or she becomes shocked.[1]
- Mother: left lateral tilt, oxygen if hypoxic, two large-bore cannulae, warmed crystalloid then blood; quantify loss rather than estimate it; compute the shock index (112 divided by 108 equals 1.04, already above the 1.0 threshold despite a reassuring blood pressure).[1][2]
- Bloods: full blood count, coagulation profile with fibrinogen, group and antibody screen, crossmatch, U&E and liver function, and a Kleihauer because she is RhD negative.[3][4]
- Fetus: auscultate then apply continuous CTG — at 32+3 weeks the trace determines whether this pregnancy continues tonight.[2]
- No digital vaginal examination until the placental site is known. Arrange urgent ultrasound for placental localisation; a speculum examination is acceptable once the site is known or in a setting where immediate caesarean is possible.[1]
- Catheterise, warm, and document a running quantitative loss total.[1]
(b) Differential diagnosis with discriminators (4 marks)
One mark per cause with its discriminating feature. No mark for a bare list. [1][2]
| Cause | The feature that discriminates it |
|---|---|
| Placenta praevia | Painless bright red bleeding, soft non-tender uterus, high or unengaged presenting part — fits this woman |
| Placental abruption | Pain usually precedes the bleeding, dark loss, tense tender uterus that will not relax, early CTG abnormality |
| Vasa praevia | Bleeding at rupture of membranes with immediate fetal bradycardia while the mother stays well |
| Uterine rupture or scar dehiscence | Previous caesarean, scar pain, loss of station, fetal bradycardia, maternal collapse |
| Local genital tract cause | Cervical ectropion, polyp, cervicitis or malignancy — found on speculum, not on scan |
| Unknown origin | A diagnosis of exclusion, still associated with preterm birth and adverse perinatal outcome |
A mark is available for stating that a normal ultrasound does not exclude abruption because sonographic sensitivity is low. [7]
(c) Rhesus management (3 marks)
One mark each for the agent with dose and route, the timing, and the laboratory testing with its purpose. [3][4]
- Give Rh D immunoglobulin 625 IU IM in Australia and New Zealand (500 IU IM is the United Kingdom dose after 20 weeks) as soon as possible, ideally within 72 hours; a dose given up to 10 days later still offers some protection.[3]
- Do not wait for the laboratory. The first dose is given on clinical grounds; testing determines whether an additional dose is required, not whether to give the first one.[3][4]
- Send a maternal sample for fetomaternal haemorrhage quantification — Kleihauer acid-elution screening, with flow cytometry as the more accurate confirmatory method — and give a calculated top-up dose on laboratory advice if the bleed is large.[4][3]
- Repeat with repeat bleeds at approximately six-weekly intervals with re-quantification, and continue routine antenatal prophylaxis at 28 and 34 weeks in addition to sensitising-event doses.[3]
(d) Ongoing management and disposition (3 marks)
One mark each for corticosteroids with the correct regimen, neuroprotection with the correct threshold, and a defensible plan for the place and timing of birth. [5][6]
- Admit. A 400 mL bleed is a major antepartum haemorrhage; she stays until stable, and given the previous caesarean the placental site report must comment explicitly on accreta features if she has a praevia.[1]
- Betamethasone 11.4 mg IM, two doses 24 hours apart (or dexamethasone 6 mg IM for four doses 12 hours apart) — a single course reduces perinatal death, respiratory distress syndrome and intraventricular haemorrhage.[5]
- Magnesium sulphate 4 g IV over 20 to 30 minutes then 1 g/h for fetal neuroprotection only if birth under 30 weeks is anticipated in Australia and New Zealand — at 32+3 weeks she is above the ANZ threshold, and saying so earns the mark.[6]
- Ongoing surveillance: serial growth scans, fetal wellbeing assessment, iron optimisation, a valid group and screen maintained, and a documented plan for the place and timing of birth with a third-stage plan written in advance.[1][8]
- Discharge criteria if she settles: no further bleeding, normal CTG, anti-D given, close to hospital with reliable transport and a companion, and explicit instructions to return immediately with any further loss.[1]
References8ShowHide
- [1]Jauniaux E, Bhide A, Hussein AM, et al. Placenta Praevia and Placenta Accreta Spectrum: Diagnosis and Management: Green-Top Guideline No. 27a BJOG, 2026.PMID 42374711
- [2]Oyelese Y, Ananth CV Placental abruption Obstet Gynecol, 2006.PMID 17012465
- [3]Qureshi H, Massey E, Kirwan D, et al. BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn Transfus Med, 2014.PMID 25121158
- [4]Porter L, Hazell M, Eggington J, et al. BSH guideline for the estimation of fetomaternal haemorrhage Transfus Med, 2026.PMID 42286430
- [5]McGoldrick E, Stewart F, Parker R, Dalziel SR Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth Cochrane Database Syst Rev, 2020.PMID 33368142
- [6]Shepherd ES, Goldsmith S, Doyle LW, et al. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus Cochrane Database Syst Rev, 2024.PMID 38726883
- [7]Glantz C, Purnell L Clinical utility of sonography in the diagnosis and treatment of placental abruption J Ultrasound Med, 2002.PMID 12164566
- [8]Bhandari S, Raja EA, Shetty A, Bhattacharya S Maternal and perinatal consequences of antepartum haemorrhage of unknown origin BJOG, 2014.PMID 24125550